Related Experiment Video

Updated: Aug 13, 2026

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment
09:56

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

Published on: April 30, 2019

MSX2 overexpression inhibits gemcitabine-induced caspase-3 activity in pancreatic cancer cells

Shin Hamada1, Kennichi Satoh, Kenji Kimura

  • 1Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai city, Miyagi 980-8574, Japan.

World Journal of Gastroenterology
|January 21, 2006
PubMed
Abstract

Insights

MSX2 (muscle segment homeobox 2) overexpression in pancreatic cancer cells reduces gemcitabine-induced apoptosis by inhibiting caspase-3 activation. This finding suggests MSX2 as a potential therapeutic target for pancreatic cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Pancreatic cancer remains a significant health challenge with limited treatment options.
  • Gemcitabine is a standard chemotherapy agent, but resistance is common.
  • Understanding molecular mechanisms regulating apoptosis is crucial for improving pancreatic cancer therapy.

Purpose of the Study:

  • To investigate the role of MSX2 (muscle segment homeobox 2) in regulating gemcitabine-induced apoptosis in Panc-1 pancreatic cancer cells.
  • To assess the impact of MSX2 overexpression on caspase-3 activation and cell viability upon gemcitabine treatment.

Main Methods:

  • Stable MSX2-overexpressing Panc-1 cells (Px14) were generated using a V5-tagged expression vector.
  • Cell viability was assessed using MTT assays.
  • Apoptosis was detected via Hoechst staining.
  • Caspase-3 activation was quantified using Western blotting and enzymatic activity assays.

Main Results:

  • MSX2 overexpression led to decreased gemcitabine-induced caspase-3 activation in Px14 cells compared to control cells.
  • Cell viability was significantly increased in MSX2-overexpressing cells treated with gemcitabine.
  • MSX2 appears to suppress the apoptotic pathway triggered by gemcitabine.

Conclusions:

  • MSX2 exerts a repressive effect on the gemcitabine-induced apoptotic pathway in pancreatic cancer cells.
  • The apoptosis-regulating function of MSX2 presents a novel therapeutic target for pancreatic cancer.
  • Further research into MSX2's role could lead to improved treatment strategies for pancreatic cancer.

More Related Videos

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...